secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2025-12-16T23:59:59+00:00
Accession:  0001493152-25-028003
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq deficiency letter for bid price non-compliance; 1-for-10 reverse stock split effected
--------------------------------------------------------------------------------

- Received Nasdaq deficiency letter on Dec 15 for closing bid price below $1 for 30 consecutive business days.
- Initial compliance period runs through June 15, 2026; cure if bid price ≥ $1 for 10 consecutive days.
- Filed and effected a 1-for-10 reverse stock split on Dec 15; split-adjusted trading began Dec 16.
- If non-compliant by June 15, may qualify for an additional 180-day period if meeting other listing standards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225028003/0001493152-25-028003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225028003/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-028003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer